MAGENTA THERAPEUTICS INC (MGTA)
US55910K1088 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to MGTA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.02. This target is 45.8% above the current price.
MGTA was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about MGTA.
In the previous month the buy percentage consensus was at a similar level.
MGTA was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-02-28 | HC Wainwright & Co. | Initiate | Neutral |
| 2023-01-26 | BTIG | Downgrade | Buy -> Neutral |
| 2023-01-26 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2023-01-26 | Wedbush | Downgrade | Outperform -> Neutral |
| 2022-12-21 | BTIG | Maintains | Buy |
| 2022-08-25 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2022-05-24 | Goldman Sachs | Maintains | Buy |
| 2022-04-18 | Mizuho | Maintains | Buy |
| 2022-04-18 | BTIG | Maintains | Buy |
| 2022-01-24 | B. Riley Securities | Maintains | Buy |
| 2022-01-06 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2021-08-03 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2021-06-29 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-06-15 | BTIG | Initiate | Buy |
| 2021-05-18 | B. Riley Securities | Initiate | Buy |